Cloning an artificial gene encoding angiostatic anginex: From designed peptide to functional recombinant protein
Authors:
- Irina NesmelovaIrina Nesmelova
- Ruud P.M. DingsRDRuud P.M. Dings
- Kevin H. MayoKMKevin H. Mayo
- Victor L.J.L. ThijssenVTVictor L.J.L. Thijssen
- Arjan W. GriffioenAGArjan W. Griffioen
- 1 August 2005
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 333 (4) , 1261-1268
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Angiogenesis gene expression profiling in xenograft models to study cellular interactionsExperimental Cell Research, 2004
- Anti-tumor activity of the novel angiogenesis inhibitor anginexCancer Letters, 2003
- The designer antiangiogenic peptide anginex targets tumor endothelial cells and inhibits tumor growth in animal modelsThe FASEB Journal, 2002
- Anginex, a designed peptide that inhibits angiogenesisBiochemical Journal, 2001
- Identification of the Anti-angiogenic Site within Vascular Basement Membrane-derived TumstatinJournal of Biological Chemistry, 2001
- Cloning, Expression, andin VitroActivity of Human EndostatinBiochemical and Biophysical Research Communications, 1999
- A recipe for designing water‐soluble, β‐sheet‐forming peptidesProtein Science, 1996
- Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutantNature, 1994
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993
- Induction of angiogenesis during the transition from hyperplasia to neoplasiaNature, 1989